Literature DB >> 1595915

Prolongation of canine epidural anesthesia by liposome encapsulation of lidocaine.

T Mashimo1, I Uchida, M Pak, A Shibata, S Nishimura, Y Inagaki, I Yoshiya.   

Abstract

The purpose of our study was to produce a long-acting lidocaine by using a liposome that would entrap the drug. Egg yolk phosphatidylcholine and cholesterol were used as liposome materials. After epidural administration, the pharmacodynamics and pharmacokinetics of liposomal and free lidocaine were studied in 20 dogs. Two percent liposomal or free lidocaine (3.0 mL) was injected into the lumbar epidural space. Nerve blocking effects were estimated by measuring somatosensory evoked potentials. Recovery time from the epidural block in the liposomal lidocaine group (170 +/- 49.5 min) was approximately three times longer than that in the free lidocaine group (61 +/- 18.1 min). The areas under the drug concentration-time curves (AUC0-infinity) and time to maximal concentration (Tmax) in the liposomal lidocaine group were significantly larger than those in the free lidocaine group. These results suggest that the prolongation of epidural blockade by liposomal lidocaine is caused by a slow release of the drug from liposomes. The present study suggests that liposomal lidocaine can be used as a long-acting local anesthetic.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1595915     DOI: 10.1213/00000539-199206000-00009

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

1.  Liposphere local anesthetic timed-release for perineural site application.

Authors:  D B Masters; A J Domb
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

2.  Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-hydroxypropyl-beta-cyclodextrin complex.

Authors:  J C Fréville; G Dollo; P Le Corre; F Chevanne; R Le Verge
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

3.  Controlled release of lidocaine from injectable gels and efficacy in rat sciatic nerve block.

Authors:  A Paavola; J Yliruusi; Y Kajimoto; E Kalso; T Wahlström; P Rosenberg
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

4.  Local myotoxicity from sustained release of bupivacaine from microparticles.

Authors:  Robert Padera; Evangelia Bellas; Julie Y Tse; Daphne Hao; Daniel S Kohane
Journal:  Anesthesiology       Date:  2008-05       Impact factor: 7.892

5.  Plasma concentrations of bupivacaine after brachial plexus administration of liposome-associated and plain solutions to rabbits.

Authors:  J G Boogaerts; N D Lafont; H Luo; F J Legros
Journal:  Can J Anaesth       Date:  1993-12       Impact factor: 5.063

6.  Prolongation of epidural bupivacaine analgesia with glycerin.

Authors:  H King; C S Xiao; D J Wooten
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

7.  Adjuvants to local anesthetics: Current understanding and future trends.

Authors:  Amlan Swain; Deb Sanjay Nag; Seelora Sahu; Devi Prasad Samaddar
Journal:  World J Clin Cases       Date:  2017-08-16       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.